OWP Pharmaceuticals Email Format
Pharmaceutical ManufacturingIllinois, United States11-50 Employees
OWP Pharmaceuticals is a small pharmaceutical manufacturer based in Lisle, Illinois. It concentrates on developing and providing medications for neurological disorders, pursuing a disciplined, long-term approach to widen access to treatments. The company operates with ROW Global in a hybrid business model that blends commercial activity with humanitarian aims, using profits to support education, diagnosis, and treatment in under-resourced regions. In the United States, OWP focuses on supplying medications to providers and patients, while directing profits to ROW Global’s initiatives. The business sits within the pharmaceutical sector as a social enterprise that aims to address unmet needs in neurology beyond traditional profit goals. A recent development is the January 2026 introduction of SUBVENITE (lamotrigine) oral suspension in the U.S., marking a new commercial product availability.